Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$551.6M
-11.9% from 2023
Prescriptions
131K
$4,200.06 per claim
Patients
15K
8,307 prescribers
Total spending, 2024
$552.0M
$37,878.73 per patient
Medicare prescription drug plans paid $551.6M for Genvoya in 2024, for 131,340 prescriptions and refills to 14,562 patients (down 11.9% from 2023). The average cost per claim was $4,200.06.
New York had the highest Medicare cost for Genvoya in 2024: $68.7M for 16,574 claims, followed by Florida ($66.6M).
Harold P Katner, internal medicine in Macon, GA, had the highest Medicare cost for Genvoya in 2024: 410 claims costing $1.7M.
Genvoya is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Harold P Katner Macon, GA | Internal Medicine | 410 | 46 | $1.7M |
| Sharon D Reiley Jacksonville, FL | Nurse Practitioner | 419 | 47 | $1.6M |
| Joseph A Horvath |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 9,177 | 169,849 | 18,458 | $667.3M |
| 2023 | 8,844 | 148,411 | 16,328 | $625.8M |
| 2024 | 8,307 | 131,340 | 14,562 | $551.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 325 |
| 29 |
| $1.3M |
| Luis A Miller Miami, FL | Infectious Disease | 275 | 32 | $1.2M |
| Vani Gandhi New York, NY | Infectious Disease | 295 | 32 | $1.1M |
| Lee A Diamond Riverdale, GA | Infectious Disease | 274 | 27 | $1.1M |
| Dong Phuong H Nguyen San Francisco, CA | Pharmacist | 121 | 34 | $1.1M |
| Debra L Gase Saint Louis, MO | Nurse Practitioner | 269 | 27 | $1.1M |
| Joseph C Gathe Jr. Houston, TX | Infectious Disease | 255 | 28 | $1.1M |
| Rafael Martinez San Antonio, TX | Family Practice | 268 | 30 | $1.1M |
| John M Quale Brooklyn, NY | Internal Medicine | 270 | 24 | $1.1M |
| Margarita Lamothe Memphis, TN | Infectious Disease | 250 | 26 | $1.0M |
| Steven A Norris Indianapolis, IN | Infectious Disease | 222 | 22 | $980K |
| Leia M Hoang San Diego, CA | Pharmacist | 89 | 34 | $955K |
| Alan J Stein Brooklyn, NY | Internal Medicine | 199 | 25 | $894K |
| Marc A Johnson Charlotte, NC | Internal Medicine | 209 | 23 | $850K |
| Luis A Cisneros San Antonio, TX | Infectious Disease | 198 | 21 | $836K |
| Michael D Dorcik Biloxi, MS | Obstetrics & Gynecology | 208 | 20 | $828K |
| Frank S Rhame Minneapolis, MN | Infectious Disease | 199 | 21 | $824K |
| Michael E Dunn Tampa, FL | Infectious Disease | 197 | 22 | $819K |
| Vonda L Blasick Harrisburg, PA | Nurse Practitioner | 205 | 25 | $803K |
| Cheryl K McDonald Fort Worth, TX | Infectious Disease | 187 | 19 | $798K |
| Milton D Boden Decatur, GA | Infectious Disease | 188 | 18 | $792K |
| Alicia Barber Memphis, TN | Nurse Practitioner | 201 | 26 | $788K |
| Waref Azmeh Baton Rouge, LA | Infectious Disease | 193 | 16 | $776K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Gilead Sciences GILD | 131,432 | $552.0M |